Alnylam Pharmaceuticals Pre-Paid Expenses 2010-2025 | ALNY

Alnylam Pharmaceuticals pre-paid expenses for the quarter ending March 31, 2025 were $0.152B, a 24.53% decline year-over-year.

  • Alnylam Pharmaceuticals pre-paid expenses for 2024 were $0.117B, a 7.45% decline from 2023.
  • Alnylam Pharmaceuticals pre-paid expenses for 2023 were $0.126B, a 4.92% decline from 2022.
  • Alnylam Pharmaceuticals pre-paid expenses for 2022 were $0.133B, a 50.91% increase from 2021.

Alnylam Pharmaceuticals Pre-Paid Expenses 2010-2025 | ALNY

  • Alnylam Pharmaceuticals pre-paid expenses for 2024 were $0.117B, a 7.45% decline from 2023.
  • Alnylam Pharmaceuticals pre-paid expenses for 2023 were $0.126B, a 4.92% decline from 2022.
  • Alnylam Pharmaceuticals pre-paid expenses for 2022 were $0.133B, a 50.91% increase from 2021.